Media Information

Important Details

  • Media must pre-register on or before Friday, October 28 to attend this year's meeting in person. Media can register for in-person attendance, ie: onsite, at any time, but may be delayed at the registration desk. Please try to register in advance if you will be onsite.
  • It is necessary to register for the meeting if you are attending in person.
  • It is also necessary to register if you would like to access the Livestream version of the meeting. No Livestream registrations will be accepted after Wednesday, November 9.
  • News releases will be posted to our online newsroom when embargoes lift on November 10.
  • The electronic press kit will be sent to media on Friday, November 4. Embargoes will lift on the first day of the meeting, Thursday, November 10, at 8:00 am ET.
  • Email hollisheavenrich-jones@acaai.org to request an embargoed electronic press kit, which will be available on Thursday, November 4.

By attending the 2022 American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting in Louisville, media attendees can:

  • Listen live to scientific presentations and keynotes.
  • Set up interviews with spokespersons, allergists, and researchers.
  • Gain a perspective on groundbreaking allergy solutions by attendinig presentations given by allergists from around the country and the world.

About the Meeting

The American College of Allergy, Asthma and Immunology (ACAAI) is pleased to welcome the media to our 2022 Annual Scientific Meeting, “Advancing Allergy & Immunology Care.” The meeting will take place on November 10 – 14 at the Kentucky International Convention Center in Louisville, KY.

ACAAI's annual meeting is a recognized forum for peer-reviewed presentations of new research by allergists and allied scientists from around the world. This year's meeting will provide plenty of news opportunities for press registrants, including:

  • Scientific presentations
  • Oral and poster sessions
  • Medically challenging cases.

Journalists are invited to report on the latest developments in the treatment of allergies, asthma and immunologic disorders – conditions that affect an estimated 50 million Americans.

Embargo Policy

Abstracts: Abstracts will be published in a supplement to the November issue of Annals of Allergy, Asthma & Immunology, ACAAI’s scientific journal. Journalists covering the meeting can obtain advance copies of selected abstracts by contacting the ACAAI Public Relations staff. The ACAAI embargo will lift on all oral and poster presentations at 8:00 a.m. EST on Thursday, November 10, 2022, unless otherwise noted.

All accepted abstracts, ePosters, and oral presentation slides are embargoed until Thursday, November 10, 2022. Authors and their institutions are permitted to share only the abstract title, date of oral/ePoster presentation, and presenter name in any communication prior to November 10, 2022. Please contact Hollis Heavenrich-Jones, ACAAI Public Relations Director, hollisheavenrich-jones@acaai.org for additional information.

Press releases, media alerts, or related materials sent by authors or their institutions do not need to be reviewed by the College, but please be aware that they must not indicate ACAAI endorsement or use the ACAAI logo.

Electronic Press Kit: A press kit containing embargoed news releases will be sent via email to media outlets on Friday, November 4, 2022, and embargoes will lift on Thursday, November 10 at 8:00 am EST. All embargo dates must be adhered to.

Media Eligibility

Press admission is available to working journalists whose attendance at the meeting may result in print, broadcast or electronic coverage of the ACAAI and its individual members. Registration fees are waived for working press, defined as editorial staff of newspapers, magazines, medical or health care publications, broadcast or web-based media.

ACAAI does not issue media credentials to the following: a publication's advertising, marketing, public relations or sales representatives; publishers, editors or reporters from manufacturers; "house organs" or promotional publications; public relations staff of exhibitors or educational institutions; writers creating analyses or reports sold as a commodity to customers; or other individuals who are not actually reporting on the meeting.

Working media representatives may not be registered as exhibitors. To obtain press admission, identification certifying that you are a working member of the news media on assignment to cover the meeting is required. Business cards from established news organizations are sufficient to establish eligibility.

The ACAAI reserves the right to deny press credentials to anyone at any time.

Advance Media Registration

Registered media will receive an electronic press kit prior to the meeting.

Information regarding press registrants is proprietary. ACAAI does not release the media registration list.

Open to Media

All scientific programs are open to the press, as well as abstract concurrent sessions/poster presentations, and the exhibit hall.

Audio/Video Recording

Recording of the meeting’s scientific or educational programs for commercial or promotional purposes is not permitted.

If you have any questions, please contact:

Hollis Heavenrich­-Jones
Director, Public Relations
American College of Allergy, Asthma and Immunology
847-­725-2277
Hollisheavenrich­jones@acaai.org

Back to Top